Boehringer Ingelheim Pharmaceuticals, Inc. Faces Litigation Over Its Drug Pradaxa

Pradaxa, a drug used to help prevent strokes or serious blood clots in people who have atrial fibrillation (a condition in which the heart beats irregularly, increasing the chance of clots forming in the body, and possibly causing strokes) without heart valve disease, is facing 131 separate lawsuits for failure to warn of risk, including death.   The manufacture claims that Pradaxa does not create a higher risk of bleeding than warfarin.